NCT07706322 Adapting a Sexual Assault Prevention Intervention for Transgender Undergraduates: A One-Arm Pilot Trial
| NCT ID | NCT07706322 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Sarah Peitzmeier |
| Condition | Sexual Assault and Rape |
| Study Type | INTERVENTIONAL |
| Enrollment | 80 participants |
| Start Date | 2026-09-02 |
| Primary Completion | 2027-04-30 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 80 participants in total. It began in 2026-09-02 with a primary completion date of 2027-04-30.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The purpose of this study is to adapt and pilot a sexual assault prevention intervention for transgender and nonbinary (trans) undergraduate students. Forty percent of trans individuals (i.e., individuals whose gender identity does not align with their sex assigned at birth, inclusive of nonbinary people) are sexually assaulted during their time in college. Despite the magnitude of this issue, there are no sexual assault prevention interventions that have lowered victimization of trans students. The Enhanced Assess, Acknowledge, Act (EAAA) intervention is recommended by the Centers for Disease Control and Prevention (CDC) and is the only intervention proven to lower rape victimization by over 50% among cisgender female undergraduates. However, trans-specific vulnerabilities to violence are not addressed in EAAA, nor in the online adaptation of EAAA recently piloted by the study team called internet-delivered EAAA (IDEA3). This project will adapt and pilot IDEA3 for trans and nonbinary students to develop one of the first evidence-based sexual assault prevention interventions for trans and nonbinary young adults. Investigators will adapt IDEA3 for trans students ages 18-25 and test it in an initial group which they will use to make revisions to the program. Then, the study will collect participant survey and focus group data on feasibility and acceptability from 4 more groups of participants, revising the intervention between groups. Finally, the study will collect preliminary data on whether the program increased participants' confidence in their ability to defend themselves.
Eligibility Criteria
Inclusion criteria: * Participants must be adults ages 18 to 25, AND * Have a gender identity that differs from their sex assigned at birth (e.g. trans or nonbinary) AND * Be an undergraduate student AND * Be available during the program times, AND * Provide the contact information for another trans or nonbinary undergraduate who they would be willing to participate in the intervention with OR express willingness to being partnered with another trans or nonbinary undergraduate at their university AND * Have access to and willingness to use the videoconferencing software Zoom for the program AND * Consent to being recorded while participating. Exclusion Criteria: * Participant is less than 18 years of age or older than 25 years of age, OR * Does not identify as a trans or nonbinary individual, OR * Is not an undergraduate student, OR * Is not available during the program times, OR * Does not provide the contact information for another trans or nonbinary undergraduate student who they would be willing to participate in the intervention with AND does not express a willingness to being partnered with another undergraduate OR * Does not have access to and or is unwilling to use the videoconferencing software Zoom, OR * Does not consent to being recorded while participating.
Contact & Investigator
Sarah Peitzmeier, PhD
PRINCIPAL INVESTIGATOR
University of Maryland, College Park
Frequently Asked Questions
Who can join the NCT07706322 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, up to 25 Years, studying Sexual Assault and Rape. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07706322 currently recruiting?
Yes, NCT07706322 is actively recruiting participants. Contact the research team at speitzme@umd.edu for enrollment information.
Where is the NCT07706322 trial being conducted?
This trial is being conducted at College Park, United States.
Who is sponsoring the NCT07706322 clinical trial?
NCT07706322 is sponsored by Sarah Peitzmeier. The principal investigator is Sarah Peitzmeier, PhD at University of Maryland, College Park. The trial plans to enroll 80 participants.